Skip to Main Content (Press Enter)

Logo UNINSUBRIA
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Projects
  • Expertise & Skills

UNI-FIND
Logo UNINSUBRIA

|

UNI-FIND

uninsubria.it
  • ×
  • Home
  • Degrees
  • Courses
  • Jobs
  • People
  • Outputs
  • Organizations
  • Third Mission
  • Projects
  • Expertise & Skills
  1. Outputs

LUNG CANCER

Journal
Identifier:
E103763
ISSN:
0169-5002
  • Overview

Overview

Outputs (27)

  • ascendant
  • decrescent
A cross-market cost comparison of erlotinib versus pemetrexed for first-line maintenance treatment of patients with locally advanced or metastatic non-small-cell lung cancer
Academic Article
An electronic nose distinguishes exhaled breath of patients with Malignant Pleural Mesothelioma from controls
Academic Article
An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Academic Article
An expanded access program of erlotinib (Tarceva) in patients with advanced non-small cell lung cancer (NSCLC): Data report from Italy
Academic Article
Assessment of lung cancer mortality reduction after chest X-ray screening in smokers: A population-based cohort study in Varese, Italy
Academic Article
Chest X-rays Lung Cancer Screening in Cigarette Smokers in the Province of Varese, Italy
Academic Article
Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link?
Academic Article
Comparison of treatment costs of grade 3/4 adverse events associated with erlotinib or pemetrexed maintenance therapy for patients with advanced non-small-cell lung cancer (NSCLC) in Germany, France, Italy, and Spain
Academic Article
Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy
Academic Article
DISRUPT: a randomised phase 2 trial of ombrabulin (AVE8062) plus a taxane-platinum regimen as first-line therapy for metastatic non-small cell lung cancer
Academic Article
EORTC QLQ-C30 summary score reliably detects changes in QoL three months after anatomic lung resection for Non-Small Cell Lung Cancer (NSCLC)
Academic Article
Final results of the SENECA (SEcond line NintEdanib in non-small cell lung CAncer) trial
Academic Article
First-line nivolumab plus ipilimumab versus chemotherapy for the treatment of unresectable malignant pleural mesothelioma: patient-reported outcomes in CheckMate 743
Academic Article
Free drugs in clinical trials and their potential cost saving impact on the National Health Service: a retrospective cost analysis in Italy
Academic Article
Immune related adverse events and response to immunotherapy: Focus on corticosteroids
Academic Article
Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines
Academic Article
LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer
Academic Article
Maintenance with lanreotide in small-cell lung cancer expressing somatostatine receptors: A multicenter, randomized, phase 3 trial
Academic Article
Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
Academic Article
PERIOPERATIVE SEQUENTIAL DETERMINATIONS OF TUMOR MARKERS
Academic Article
Phase II study of irinotecan and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 007)
Academic Article
Phase II trial of customized first line chemotherapy according to ERCC1 and RRM1 SNPs in patients with advanced non-small-cell lung cancer.
Academic Article
Prognostic role of K-Ras mutations in non-small cell lung cancer: still an issue for open debate.
Academic Article
Prognostic role of the VeriStrat test in first line patients with non-small cell lung cancer treated with platinum-based chemotherapy
Academic Article
Prognostic value of Exhaled Microsatellite alterations at 3p in NSCLC patients.
Academic Article
Randomized phase III PITCAP trial and meta-analysis of induction chemotherapy followed by thoracic irradiation with or without concurrent taxane-based chemotherapy in locally advanced NSCLC
Academic Article
Sequential chemotherapy with paclitaxel plus cisplatin, followed by vinorelbine, followed by gemcitabine in advanced non-small cell lung cancer: an Alpe-Adria Thoracic Oncology Multidisciplinary group study (ATOM 001)
Academic Article
No Results Found
  • «
  • ‹
  • {pageNumber}
  • ›
  • »
{startItem} - {endItem} of {itemsNumber}
  • Accessibility
  • Use of cookies

Powered by VIVO | Designed by Cineca | 26.5.1.0